Frederic Pla's most recent trade in Akoya Biosciences Inc was a trade of 2,006 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on March 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akoya Biosciences Inc | Frederic Pla | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. | 23 Mar 2024 | 2,006 | 101,500 | - | 4.8 | 9,609 | Common Stock |
| Akoya Biosciences Inc | Frederic Pla | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Frederic Pla | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 35,000 | 105,555 | - | 0 | Common Stock | |
| Akoya Biosciences Inc | Frederic Pla | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 22 Feb 2024 | 2,049 | 103,506 | - | 6.0 | 12,355 | Common Stock |
| Akoya Biosciences Inc | Frederic Pla | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. | 23 Mar 2023 | 1,945 | 40,555 | - | 7.7 | 14,957 | Common Stock |
| Akoya Biosciences Inc | Frederic Pla | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Frederic Pla | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 20,000 | 42,500 | - | 0 | Common Stock |